Black Diamond Therapeutics (BDTX) Q4 2024 Earnings

5NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.47
-0.4
-0.34
-0.28

Details

Expected EPS
-0.373343
Actual EPS
-0.28
Surprise EPS
0.09
Surprise Percent
+25%

Description

Black Diamond Therapeutics (BDTX) has reported earnings of -0.28 per share for Q4 2024.

0 Comments

Share your thoughts